Incyte Pharmaceuticals Inc., Layton BioSciences deal

Palo Alto-based IPI entered into an agreement Layton (Atherton, Calif.), under which IPI will adapt Layton's non-PCR-based RNA amplification technology to prepare cDNA libraries from single cells and ...